Abilify and Unasyn drug interactions - a phase IV clinical study of FDA data
Summary:
Drug interactions are reported among people who take Abilify (aripiprazole) and Unasyn (ampicillin sodium; sulbactam sodium). Common drug interactions include dysphagia among females and pneumonia aspiration among males.
The phase IV clinical study analyzes what interactions people have when they take Abilify and Unasyn. It is created by eHealthMe based on reports of 35 people who take the same drugs from the FDA, and is updated regularly.
What is Abilify?
Abilify has active ingredients of aripiprazole. It is often used in depression. eHealthMe is studying from 101,456 Abilify users. Check the latest studies of Abilify.
What is Unasyn?
Unasyn has active ingredients of ampicillin sodium; sulbactam sodium. eHealthMe is studying from 4,474 Unasyn users. Check the latest studies of Unasyn.
eHealthMe: drug outcomes in the real world
eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.
35 people who take Abilify and Unasyn together, and have interactions are studied.

What are the common drug interactions of Abilify and Unasyn, by gender? *:
female:
- Dysphagia (a condition in which swallowing is difficult or painful)
- Eating disorder
- Electrocardiogram qt prolonged
- Epicondylitis (tennis elbow)
- Fatigue (feeling of tiredness)
- Gastrointestinal haemorrhage (bleeding gastrointestinal tract)
- Gastrooesophageal reflux disease (stomach contents (food or liquid) leak backwards from the stomach into the oesophagus)
- General physical health deterioration (weak health status)
- Gingival bleeding (bleeding gums)
- Gingival erosion (gum ulcer)
male:
- Pneumonia aspiration (bronchopneumonia that develops due to the entrance of foreign materials into the bronchial tree)
- Agitation (state of anxiety or nervous excitement)
- Cellulitis (infection under the skin)
- Chest pain
- Cholecystitis acute (rapid infection of gallbladder)
- Cough
- Diabetes mellitus (diabetes, caused by a deficiency of the pancreatic hormone insulin)
- Diarrhoea
- Drug abuse
- Gastroenteritis (inflammation of stomach and intestine)
What are the common drug interactions of Abilify and Unasyn, by age (0-1 to 60+)? *:
0-1:
n/a
2-9:
n/a
10-19:
n/a
20-29:
- Neuroleptic malignant syndrome (a life-threatening neurological disorder most often caused by an adverse reaction to neuroleptic or antipsychotic agents)
- Tonic convulsion (the person will quickly lose consciousness and the skeletal muscles will suddenly tense, often causing the extremities to be pulled towards the body or rigidly pushed away from it)
30-39:
- Abdominal pain
- Abdominal pain lower
- Acute coronary syndrome (acute chest pain and other symptoms that happen because the heart does not get blood)
- Anxiety
- Bronchitis (inflammation of the mucous membrane in the bronchial tubes)
- Cellulitis (infection under the skin)
- Chest pain
- Cholecystitis acute (rapid infection of gallbladder)
- Cough
- Diabetes mellitus (diabetes, caused by a deficiency of the pancreatic hormone insulin)
40-49:
- Agitation (state of anxiety or nervous excitement)
- Hyperthermia (body temperature greatly above normal)
- Pneumonia aspiration (bronchopneumonia that develops due to the entrance of foreign materials into the bronchial tree)
- Nephrogenic diabetes insipidus (a disorder in which a defect in the small tubes (tubules) in the kidneys causes a person to pass a large amount of urine)
- Overdose
- Abdominal pain
- Anogenital warts
- Coronary artery disease (plaque building up along the inner walls of the arteries of the heart, which narrows the arteries and restricts blood flow to the heart)
- Drug level decreased
- Enteritis (inflammation of the small intestine)
50-59:
- Abdominal pain
- Acinetobacter infection (infection by group of bacteria commonly found in soil and water)
- Arteriosclerosis (thickening and hardening of arteries)
- Asthma
- Blood pressure decreased
- Blood pressure increased
- Cardiac failure
- Cardiac failure congestive
- Cerebrovascular accident (sudden death of some brain cells due to lack of oxygen when the blood flow to the brain is impaired by blockage or rupture)
- Chest discomfort
60+:
- Chest pain
- Fall
- Spinal column injury (spinal cord bone injury)
- Dermatitis allergic (inflammation of the skin due allergic reaction)
- Laceration (tearing of soft body tissue)
- Dysphagia (a condition in which swallowing is difficult or painful)
- Joint swelling
- Abscess jaw (tooth abscess or root abscess)
- Aggression
- Anaemia (lack of blood)
What are the existing conditions these people have? *
- Major Depression (a mood state that goes well beyond temporarily feeling sad or blue. it is a serious medical illness that affects one's thoughts, feelings): 7 people, 20.00%
- Agitation (state of anxiety or nervous excitement): 6 people, 17.14%
- Schizophrenia (a mental disorder characterized by a breakdown of thought processes): 5 people, 14.29%
- Diabetes Insipidus - Nephrogenic (diabetes caused by a deficiency of the pituitary hormone vasopressin, which regulates kidney function): 5 people, 14.29%
- Infection: 4 people, 11.43%
- Pain: 3 people, 8.57%
- Epilepsy (common and diverse set of chronic neurological disorders characterized by seizures): 3 people, 8.57%
- Sleep Disorder: 2 people, 5.71%
- Persecutory Delusion: 2 people, 5.71%
- Osteoporosis (bones weak and more likely to break): 2 people, 5.71%
* Approximation only. Some reports may have incomplete information.
Do you take Abilify and Unasyn?
- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously
Related studies:
Effectiveness of, side effects of, and alternative drugs to the 2 drugs:
Browse all drug interactions of Abilify and Unasyn:
a b c d e f g h i j k l m n o p q r s t u v w x y zSub-studies by gender and age:
Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+
Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+
Browse all side effects of Abilify:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all side effects of Unasyn:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all interactions between Abilify and drugs from A to Z:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all interactions between Unasyn and drugs from A to Z:
a b c d e f g h i j k l m n o p q r s t u v w x y zRelated publications that referenced our studies
- Cetin, M., Celik, M., Cakici, M., Polat, M., & Suner, A, "Aripiprazole-Induced Hoarseness", Turk Psikiyatri Dergisi, 2018 Jan .
- Cetin M, Celik M, Cakici M, Polat M, Suner A, "Aripiprazole induced non-cardiogenic pulmonary edema: a case report", Turk Psikiyatri Dergisi, 2014 Dec .
- Cetin, M., Celik, M., Cakici, M., Polat, M., & Suner, A, "Aripiprazole-Induced Hoarseness", Turk Psikiyatri Dergisi, 2018 Jan .
- Cetin M, Celik M, Cakici M, Polat M, Suner A, "Aripiprazole induced non-cardiogenic pulmonary edema: a case report", Turk Psikiyatri Dergisi, 2014 Dec .
How the study uses the data?
The study uses data from the FDA. It is based on aripiprazole and ampicillin sodium; sulbactam sodium (the active ingredients of Abilify and Unasyn, respectively), and Abilify and Unasyn (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.
How to use the study?
DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.
Who is eHealthMe?
With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).
WARNING, DISCLAIMER, USE FOR PUBLICATION
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.
Recent studies on eHealthMe:
- Could Celebrex cause Hyperreflexia? - 2 seconds ago
- Could Lortab cause Poor Quality Sleep? - 2 seconds ago
- Could Lortab cause Anorectal Discomfort? - 11 seconds ago
- Could Loraz cause Vascular Rupture? - 36 seconds ago
- Could Creon cause Partial Seizures? - 36 seconds ago
- Could Loraz cause Pneumonia Pneumococcal? - 37 seconds ago
- Could Loraz cause Implant Site Infection? - 38 seconds ago
- Could Amoxicillin And Clavulanate Potassium cause Bone Disorder? - 49 seconds ago
- Could Lopressor cause Heart Rate Irregular? - 56 seconds ago
- Could Lopurin cause Dyslipidaemia? - 58 seconds ago